当前位置: 首页 > 医疗版 > 疾病专题 > 耳鼻喉科 > 耳鼻咽喉异物及肿瘤 > 耳鼻咽喉肿瘤 > 喉癌
编号:13582405
mmiR936对人喉癌细胞株Hep2增殖、迁移、侵袭和药物敏感性的影响(1)
http://www.100md.com 2018年6月1日 《新医学》 20186
     【摘要】目的探讨微小RNA936(miR936)对人类喉癌细胞株Hep2增殖、迁移、侵袭和药物敏感性的影响。方法通过慢病毒感染构建miR936过表达的喉癌细胞株Hep2细胞系(miR936组)及空载对照组(Vector组)。荧光显微镜观察病毒感染效率,实时荧光定量PCR检測2组细胞miR936的表达量。MTT增殖实验分析2组细胞增殖能力的变化。MTT药敏实验比较2组细胞药物敏感性的变化。划痕实验和Transwell小室实验分别检测2组细胞迁移和侵袭能力,激光共聚焦扫描显微镜观察细胞骨架变化。结果miR936组Hep2细胞的miR936mRNA表达水平高于Vector组(t=5600,P<005)。miR936组Hep2细胞增殖能力明显低于Vector组。培养24h和48h时miR936组Hep2细胞的迁移能力均低于Vector组(P均<001);miR936组细胞的侵袭能力低于Vector组(P<001);此外,miR936过表达后Hep2细胞的微管微丝与Vector组相比减少。药物敏感实验结果显示miR936组Hep2细胞对顺铂和阿霉素的敏感性较Vector组增加(均P<005)。结论miR936可以抑制Hep2细胞的增殖、迁移和侵袭,并且能够增加Hep2细胞对顺铂和阿霉素的敏感性。
, http://www.100md.com
    【关键词】喉肿瘤;微小RNA;增殖;迁移;侵袭;药物敏感性

    EffectsofmicroRNA936ontheproliferation,migration,invasionanddrugsensitivityofhumanlaryngealcancercelllineHep2WangHaifeng,LiPei,WangZhiyuan,LinXijun,GuoCheng,YeJinDepartmentofOtolaryngologyHeadNeckSurgery,theThirdAffiliatedHospitalofSunYatsenUniversity,Guangzhou510630,China

    Correspondingauthor,YeJin,Email:yejin_sums@aliyuncom

    【Abstract】ObjectiveToinvestigatetheeffectofmicroRNA936(miR936)ontheproliferation,migration,invasionanddrugsensitivityofhumanlaryngealcancercelllineHep2MethodsTheHep2celllineoverexpressingmiR936(miR936group)andtheemptyvectorcontrolgroup(vectorgroup)wereconstructedbylentivirusinfectionTheefficiencyofvirusinfectionwasobservedbyfluorescencemicroscopeTheexpressionofmiR936wasdetectedbyRTqPCRMTTproliferationassaywasusedtoanalyzethechangesofcellproliferationinbothgroupsMTTdrugsensitivityassaywasperformedtocomparethechangesofdrugsensitivityinbothgroupsCellmigrationandinvasionabilityintwogroupswasevaluatedbyTranswellchamberassayConfocalmicroscopewasadoptedtoobservethevariationsincellcytoskeletonResultsTheexpressionlevelofmiR936mRNAofHep2cellsinthemiR936groupwassignificantlyhigherthanthatinthevectorgroup(t=5600,P<005)InthemiR936group,theproliferationcapacityofHep2cellswassignificantlylowercomparedwiththatinthevectorgroupThemigrationabilityofHep2cellsinthemiR936groupwassignificantlylowerthanthatinthevectorgroupat24hand48hafterculture(bothP<001)ThecellinvasionabilityinthemiR936groupwasconsiderablylowerthanthatinthevectorgroup(P<001)ThequantityofmicrotubulesofHep2cellswassignificantlyreducedafteroverexpressionofmiR936comparedwiththatinthevectorgroupDrugsensitivitytestdemonstratedthatthesensitivityofHep2cellstocisplatinandadriamycinwassignificantlyincreasedinthemiR936groupcomparedwiththatinthevectorgroup(P<001)ConclusionmiR936caninhibittheproliferation,migrationandinvasionofHep2cells,andcanincreasethesensitivityofHep2cellstocisplatinandadriamycin, 百拇医药(王海峰 李培 王志远 林惜君 郭程 叶进)
1 2 3 4下一页


    参见:首页 > 医疗版 > 疾病专题 > 耳鼻喉科 > 耳鼻咽喉异物及肿瘤 > 耳鼻咽喉肿瘤 > 喉癌